Contact
searchSearch
HMP Global

Pediatric Dermatology Topic Center

Featured

FDA Alerts
FDA Approves Vyjuvek for Treatment of Wounds in Patients with Dystrophic Epidermolysis Bullosa
08/10/2023
Jessica Garlewicz
The US Food and Drug Administration recently announced approval of VYJUVEK (beremagene geperpavec [B-VEC]) for the treatment of wounds in patients ages 6 months and older with dystrophic epidermolysis bullosa.
The US Food and Drug Administration recently announced approval of VYJUVEK (beremagene geperpavec [B-VEC]) for the treatment of wounds in patients ages 6 months and older with dystrophic epidermolysis bullosa.
The US Food and Drug...
08/10/2023
The Dermatologist
News
Patients With Pediatric Granuloma Annulare Often Present With Asthma and Atopy
01/31/2023
Lisa Kuhns, PhD, MD
Researchers aimed to perform a clinical and histopathologic evaluation of 41 pediatric GA cases in a retrospective study.
Researchers aimed to perform a clinical and histopathologic evaluation of 41 pediatric GA cases in a retrospective study.
Researchers aimed to perform a...
01/31/2023
The Dermatologist
CH
Videos
How to Teach Families About Safe Hair Care for Skin of Color
01/17/2022
Candrice Heath, MD, FAAP, FAAD
Candrice Heath, MD, discusses how to teach families about safe hair care practices for skin of color.
Candrice Heath, MD, discusses how to teach families about safe hair care practices for skin of color.
Candrice Heath, MD, discusses...
01/17/2022
The Dermatologist
CH
Videos
Integrating Skin of Color Hair Care for Young Patients
01/09/2022
Candrice Heath, MD, FAAP, FAAD
In this video, Candrice Heath, MD, shares what dermatologists should consider when treating skin of color hair in younger patients.
In this video, Candrice Heath, MD, shares what dermatologists should consider when treating skin of color hair in younger patients.
In this video, Candrice Heath,...
01/09/2022
The Dermatologist
News
Tobacco Exposure Linked to Childhood Psoriasis
12/23/2021
Lauren Mateja
A study in Pediatric Dermatology found that environmental tobacco smoke exposure at home was associated with childhood psoriasis in a Turkish population study.
A study in Pediatric Dermatology found that environmental tobacco smoke exposure at home was associated with childhood psoriasis in a Turkish population study.
A study in Pediatric Dermatology...
12/23/2021
The Dermatologist
News
Paraben Exposure Increases Atopic Dermatitis Prevalence in Young Children
12/18/2021
Lisa Kuhns, PhD, MD
High exposure to parabens in children aged 0 to 3 years increased the prevalence of atopic dermatitis (AD), according to a recent study from Japan.
High exposure to parabens in children aged 0 to 3 years increased the prevalence of atopic dermatitis (AD), according to a recent study from Japan.
High exposure to parabens in...
12/18/2021
The Dermatologist
News
Atopic Dermatitis Associated With Shorter Stature and Higher BMI in Children
12/13/2021
Lisa Kuhns, PhD, MD
Atopic dermatitis in children is associated with shorter stature, higher BMI, and lower weight in early childhood, but these associations resolve with age.
Atopic dermatitis in children is associated with shorter stature, higher BMI, and lower weight in early childhood, but these associations resolve with age.
Atopic dermatitis in children is...
12/13/2021
The Dermatologist
News
Pediatric Urticaria Resolution Associated With Elevated CD63 Levels and Thyroid Comorbidity
04/13/2021
Elevated CD63 levels and thyroid disease are associated with chronic inducible urticaria (CIndU) resolution in pediatric patients.
Elevated CD63 levels and thyroid disease are associated with chronic inducible urticaria (CIndU) resolution in pediatric patients.
Elevated CD63 levels and thyroid...
04/13/2021
The Dermatologist
News
Metabolic Syndrome and Insulin Resistance Found in Pre-Pubertal Children With Psoriasis
01/29/2021
A high prevalence of metabolic syndrome (MetS) and insulin resistance exists in pre-pubertal children with psoriasis, according to a recent publication in the European Journal of Pediatrics.
A high prevalence of metabolic syndrome (MetS) and insulin resistance exists in pre-pubertal children with psoriasis, according to a recent publication in the European Journal of Pediatrics.
A high prevalence of metabolic...
01/29/2021
The Dermatologist
News
Itch NRS Suitable for Pediatric Psoriasis Population
01/04/2021
Use of the Itch Numeric Rating Scale (NRS) in adults with psoriasis is common, but standard use in a similar pediatric population has not been established. A qualitative study supports the content validity of the Itch NRS for pediatric...
Use of the Itch Numeric Rating Scale (NRS) in adults with psoriasis is common, but standard use in a similar pediatric population has not been established. A qualitative study supports the content validity of the Itch NRS for pediatric...
Use of the Itch Numeric Rating...
01/04/2021
The Dermatologist
Q&As
Amplifying the Voice of Women in Pediatric Dermatology
12/14/2020
Lauren Mateja
Women have found an increasing presence throughout dermatology both at a general and subspecialty level, but gaps in representation remain.  Over the past decade, women have found a growing role in the...
Women have found an increasing presence throughout dermatology both at a general and subspecialty level, but gaps in representation remain.  Over the past decade, women have found a growing role in the...
...
12/14/2020
The Dermatologist

Expert Insights

CH
Videos
How to Teach Families About Safe Hair Care for Skin of Color
01/17/2022
Candrice Heath, MD, FAAP, FAAD
Candrice Heath, MD, discusses how to teach families about safe hair care practices for skin of color.
Candrice Heath, MD, discusses how to teach families about safe hair care practices for skin of color.
Candrice Heath, MD, discusses...
01/17/2022
The Dermatologist
CH
Videos
Integrating Skin of Color Hair Care for Young Patients
01/09/2022
Candrice Heath, MD, FAAP, FAAD
In this video, Candrice Heath, MD, shares what dermatologists should consider when treating skin of color hair in younger patients.
In this video, Candrice Heath, MD, shares what dermatologists should consider when treating skin of color hair in younger patients.
In this video, Candrice Heath,...
01/09/2022
The Dermatologist
Q&As
Amplifying the Voice of Women in Pediatric Dermatology
12/14/2020
Lauren Mateja
Women have found an increasing presence throughout dermatology both at a general and subspecialty level, but gaps in representation remain.  Over the past decade, women have found a growing role in the...
Women have found an increasing presence throughout dermatology both at a general and subspecialty level, but gaps in representation remain.  Over the past decade, women have found a growing role in the...
...
12/14/2020
The Dermatologist
eee
Podcasts
Dr Heath Shares Clinical Pearls for Treating Pediatric Patients
10/02/2020
Candrice Heath, MD, shared her insights on treating pediatric patients, and why it is important for all dermatologists, including those who only see adults, to learn about treating younger patients.
Candrice Heath, MD, shared her insights on treating pediatric patients, and why it is important for all dermatologists, including those who only see adults, to learn about treating younger patients.
Candrice Heath, MD, shared her...
10/02/2020
The Dermatologist
More to Skin Than Meets the Eye: Bullying and Childhood Skin Conditions
Cover Story
More to Skin Than Meets the Eye: Bullying and Childhood Skin Conditions
09/11/2020
Sasha D. Jaquez, PhD; Maria A. Leszczynska, MD
Bullying is common in childhood, and children with visible skin conditions can be highly vulnerable. Dermatologists can play a critical role into helping their pediatric patients through early screening and management.
Bullying is common in childhood, and children with visible skin conditions can be highly vulnerable. Dermatologists can play a critical role into helping their pediatric patients through early screening and management.
Bullying is common in childhood,...
09/11/2020
The Dermatologist
Feature Story
Treating Molluscum Contagiosum: Current Choices vs the Future Pipeline
02/13/2020
Without approved treatment options for molluscum contagiosum, doctors have differing opinions on how and even whether to treat. Recent interviews with dermatologists and pediatricians offer insight into the treatments that these two...
Without approved treatment options for molluscum contagiosum, doctors have differing opinions on how and even whether to treat. Recent interviews with dermatologists and pediatricians offer insight into the treatments that these two...
Without approved treatment...
02/13/2020
The Dermatologist
Katrina Abuabara
Videos
Systemic Treatments for Special Populations in Dermatology
09/10/2025
Katrina Abuabara, MD, MA, MSCE
Dr Katrina Abuabara shares strategies for safely prescribing systemic therapies in special populations with atopic dermatitis—covering pregnancy, older adults, comorbidities, drug interactions, and real-world data limitations.
Dr Katrina Abuabara shares strategies for safely prescribing systemic therapies in special populations with atopic dermatitis—covering pregnancy, older adults, comorbidities, drug interactions, and real-world data limitations.
Dr Katrina Abuabara shares...
09/10/2025
The Dermatologist
Cover Story
Janus Kinase Inhibitors and Alopecia Areata: From Data to Dialogue
09/08/2025
Justin M. Ko, MD, MBA
Dr Justin Ko shares patient-centered strategies for discussing boxed warnings, risk assessment, and therapeutic goals.
Dr Justin Ko shares patient-centered strategies for discussing boxed warnings, risk assessment, and therapeutic goals.
Dr Justin Ko shares...
09/08/2025
The Dermatologist
Feature Story
Two Roads Diverging: The Future of Patient Communication in the Era of Artificial Intelligence
09/08/2025
Ross Lane Pearlman, MD
Without a doubt, the rise of large language model applications will affect the dialogue between patients and physicians.
Without a doubt, the rise of large language model applications will affect the dialogue between patients and physicians.
Without a doubt, the rise of...
09/08/2025
The Dermatologist
HSF-Reviewed Features
Optimizing HS Visits: A Dermatologist’s Guide to Compassionate, Effective Care
09/08/2025
Gretchen M. Roth, MD, FAAD; Precious A. Anyanwu
Together, we can improve hidradenitis suppurativa care and help improve the lives of our patients.
Together, we can improve hidradenitis suppurativa care and help improve the lives of our patients.
Together, we can improve...
09/08/2025
The Dermatologist
part 2
Videos
Part 2: From Topicals to Biologics: Evolution of Treatment Options in Severe Alopecia Areata
09/08/2025
Brittany Craiglow, MD; Brett A. King, MD, PhD; Maryanne Makredes Senna, MD
Explore how the treatment of severe alopecia areata has evolved—from topicals to cutting-edge FDA-approved JAK inhibitors—in this expert-led discussion featuring Drs. Craiglow, King, and Senna. Learn practical clinical strategies, safety...
Explore how the treatment of severe alopecia areata has evolved—from topicals to cutting-edge FDA-approved JAK inhibitors—in this expert-led discussion featuring Drs. Craiglow, King, and Senna. Learn practical clinical strategies, safety...
Explore how the treatment of...
09/08/2025
The Dermatologist
Dr Omid Hamid
Videos
Derm Advances: Insights From Dr Hamid on the Phase 3 C-POST Trial Results
08/15/2025
Omid Hamid, MD
08/15/2025
The Dermatologist
Glynis Ablon, MD, and Neil Sadick, MD presenters
Videos
Expert Perspectives: Hair Loss Management in Dermatology Practice
08/08/2025
Neil S. Sadick, MD, FAAD; Glynis Ablon
This presentation explores the rising prevalence of hair loss and the expanding range of treatment options available to dermatologists. It outlines the most common hair loss conditions and highlights the emotional and psychological impact on...
This presentation explores the rising prevalence of hair loss and the expanding range of treatment options available to dermatologists. It outlines the most common hair loss conditions and highlights the emotional and psychological impact on...
This presentation explores the...
08/08/2025
The Dermatologist
Part 1 roundtable
Q&As
Part 1: Understanding the Emotional and Physical Toll of Alopecia Areata
08/04/2025
Brittany Craiglow, MD; Brett A. King, MD, PhD; Maryanne Makredes Senna, MD
In this candid and powerful conversation, Dr Brittany Craiglow, Dr Brett King, and Dr Maryanne Senna share their clinical experiences treating patients with severe alopecia areata.
In this candid and powerful conversation, Dr Brittany Craiglow, Dr Brett King, and Dr Maryanne Senna share their clinical experiences treating patients with severe alopecia areata.
In this candid and powerful...
08/04/2025
The Dermatologist
Cover Story
Type 2 Inflammation in Atopic Dermatitis
08/02/2025
Mona Shahriari, MD, FAAD
Join Dr Mona Shahriari for a high-level primer on how type 2 immune dysregulation drives this disease.
Join Dr Mona Shahriari for a high-level primer on how type 2 immune dysregulation drives this disease.
Join Dr Mona Shahriari for a...
08/02/2025
The Dermatologist
Feature Story
GLP-1 Agonists: Implications for Dermatology
08/02/2025
Serene Majid, BA; Steven R. Feldman, MD, PhD
This article provides an accessible overview of the pharmacologic mechanisms of glucagon-like peptide-1 receptor agonists, the utility of these drugs in obesity, and their potential applications in managing inflammatory skin disease.
This article provides an accessible overview of the pharmacologic mechanisms of glucagon-like peptide-1 receptor agonists, the utility of these drugs in obesity, and their potential applications in managing inflammatory skin disease.
This article provides an...
08/02/2025
The Dermatologist

News and Quizzes

FDA Alerts
FDA Approves Vyjuvek for Treatment of Wounds in Patients with Dystrophic Epidermolysis Bullosa
08/10/2023
Jessica Garlewicz
The US Food and Drug Administration recently announced approval of VYJUVEK (beremagene geperpavec [B-VEC]) for the treatment of wounds in patients ages 6 months and older with dystrophic epidermolysis bullosa.
The US Food and Drug Administration recently announced approval of VYJUVEK (beremagene geperpavec [B-VEC]) for the treatment of wounds in patients ages 6 months and older with dystrophic epidermolysis bullosa.
The US Food and Drug...
08/10/2023
The Dermatologist
News
Patients With Pediatric Granuloma Annulare Often Present With Asthma and Atopy
01/31/2023
Lisa Kuhns, PhD, MD
Researchers aimed to perform a clinical and histopathologic evaluation of 41 pediatric GA cases in a retrospective study.
Researchers aimed to perform a clinical and histopathologic evaluation of 41 pediatric GA cases in a retrospective study.
Researchers aimed to perform a...
01/31/2023
The Dermatologist
News
Tobacco Exposure Linked to Childhood Psoriasis
12/23/2021
Lauren Mateja
A study in Pediatric Dermatology found that environmental tobacco smoke exposure at home was associated with childhood psoriasis in a Turkish population study.
A study in Pediatric Dermatology found that environmental tobacco smoke exposure at home was associated with childhood psoriasis in a Turkish population study.
A study in Pediatric Dermatology...
12/23/2021
The Dermatologist
News
Paraben Exposure Increases Atopic Dermatitis Prevalence in Young Children
12/18/2021
Lisa Kuhns, PhD, MD
High exposure to parabens in children aged 0 to 3 years increased the prevalence of atopic dermatitis (AD), according to a recent study from Japan.
High exposure to parabens in children aged 0 to 3 years increased the prevalence of atopic dermatitis (AD), according to a recent study from Japan.
High exposure to parabens in...
12/18/2021
The Dermatologist
News
Atopic Dermatitis Associated With Shorter Stature and Higher BMI in Children
12/13/2021
Lisa Kuhns, PhD, MD
Atopic dermatitis in children is associated with shorter stature, higher BMI, and lower weight in early childhood, but these associations resolve with age.
Atopic dermatitis in children is associated with shorter stature, higher BMI, and lower weight in early childhood, but these associations resolve with age.
Atopic dermatitis in children is...
12/13/2021
The Dermatologist
News
Pediatric Urticaria Resolution Associated With Elevated CD63 Levels and Thyroid Comorbidity
04/13/2021
Elevated CD63 levels and thyroid disease are associated with chronic inducible urticaria (CIndU) resolution in pediatric patients.
Elevated CD63 levels and thyroid disease are associated with chronic inducible urticaria (CIndU) resolution in pediatric patients.
Elevated CD63 levels and thyroid...
04/13/2021
The Dermatologist
acne
Quiz
Quiz: Pathophysiologic Pillars of Acne
09/25/2025
Jessica Garlewicz
Which of the following is not 1 of the 4 core pathophysiologic pillars of acne?
Which of the following is not 1 of the 4 core pathophysiologic pillars of acne?
Which of the following is not 1...
09/25/2025
The Dermatologist
psoriasis
Quiz
Quiz: Risk of Developing Psoriatic Arthritis in Patients with Psoriasis
09/25/2025
Jessica Garlewicz
Which of the following clinical features is most strongly associated with an increased risk of developing psoriatic arthritis in patients with psoriasis?
Which of the following clinical features is most strongly associated with an increased risk of developing psoriatic arthritis in patients with psoriasis?
Which of the following clinical...
09/25/2025
The Dermatologist
Quiz
When Should You Start a JAK Inhibitor for AA?
09/22/2025
Riya Gandhi, MA
Clinicians vary in when they escalate to JAK inhibitor therapy for alopecia areata. Take the quiz to see if your threshold aligns with current expert consensus.
Clinicians vary in when they escalate to JAK inhibitor therapy for alopecia areata. Take the quiz to see if your threshold aligns with current expert consensus.
Clinicians vary in when they...
09/22/2025
The Dermatologist
AD
FDA Alerts
FDA Approves Opzelura for Atopic Dermatitis in Children Aged 2–11
09/18/2025
Riya Gandhi, MA
US FDA approved Opzelura (ruxolitinib) cream 1.5% for the short-term and noncontinuous chronic treatment of mild-to-moderate AD in nonimmunocompromised children aged 2 years and older.
US FDA approved Opzelura (ruxolitinib) cream 1.5% for the short-term and noncontinuous chronic treatment of mild-to-moderate AD in nonimmunocompromised children aged 2 years and older.
US FDA approved Opzelura...
09/18/2025
The Dermatologist
Quiz
Which Systemic Therapy Raises Red Flags in Older Adults?
09/18/2025
Riya Gandhi, MA
Older patients need special consideration. Take the quiz to identify which systemic drug class carries higher risks—like thrombosis and malignancy—and requires extra caution in aging populations.
Older patients need special consideration. Take the quiz to identify which systemic drug class carries higher risks—like thrombosis and malignancy—and requires extra caution in aging populations.
Older patients need special...
09/18/2025
The Dermatologist
Quiz
How Long Before You Call a JAK Inhibitor Non-Responsive?
09/15/2025
Riya Gandhi, MA
What’s the minimum trial duration before judging JAK efficacy in AA? Test your clinical timing.
What’s the minimum trial duration before judging JAK efficacy in AA? Test your clinical timing.
What’s the minimum trial...
09/15/2025
The Dermatologist
FDA Alerts
Anzupgo Available for Prescribing Today
09/08/2025
Coleen Stern, MA
FDA recently approved delgocitinib cream as the first and only treatment indicated for moderate-to-severe chronic hand eczema in adults.
FDA recently approved delgocitinib cream as the first and only treatment indicated for moderate-to-severe chronic hand eczema in adults.
FDA recently approved...
09/08/2025
The Dermatologist
Quiz
What’s the Go-To Adjunct With JAKs in AA Regrowth?
09/08/2025
Riya Gandhi, MA
JAK inhibitors are central, but what’s commonly used alongside them in practice to boost hair regrowth? Take the quiz to find out.
JAK inhibitors are central, but what’s commonly used alongside them in practice to boost hair regrowth? Take the quiz to find out.
JAK inhibitors are central, but...
09/08/2025
The Dermatologist
psoriasis
Quiz
NPF Quiz: The Primary Goal of the S.T.R.A.N.D. Network
09/04/2025
Jessica Garlewicz
What is one of the primary goals of the S.T.R.A.N.D. Network as described by Dr Chesahna Kindred?
What is one of the primary goals of the S.T.R.A.N.D. Network as described by Dr Chesahna Kindred?
What is one of the primary goals...
09/04/2025
The Dermatologist
psoriatic arthritis
News
Rare Case Highlights Diagnostic and Treatment Challenges in PsA–Myopathy Overlap
09/02/2025
Jessica Garlewicz
The case study, accompanied by a review of 17 similar reports, details shared immunopathogenesis and conflicting treatment responses in this rare overlap syndrome.
The case study, accompanied by a review of 17 similar reports, details shared immunopathogenesis and conflicting treatment responses in this rare overlap syndrome.
The case study, accompanied by a...
09/02/2025
The Dermatologist
New Issue - September 2025

Current Issue

September 2025
Volume 33
Issue 6
Current Issue
Issue Archive
The Dermatologist Newsletter

Recent News

FDA Alerts
FDA Approves Vyjuvek for Treatment of Wounds in Patients with Dystrophic Epidermolysis Bullosa
08/10/2023
Jessica Garlewicz
The US Food and Drug Administration recently announced approval of VYJUVEK (beremagene geperpavec [B-VEC]) for the treatment of wounds in patients ages 6 months and older with dystrophic epidermolysis bullosa.
The US Food and Drug Administration recently announced approval of VYJUVEK (beremagene geperpavec [B-VEC]) for the treatment of wounds in patients ages 6 months and older with dystrophic epidermolysis bullosa.
The US Food and Drug...
08/10/2023
The Dermatologist
News
Patients With Pediatric Granuloma Annulare Often Present With Asthma and Atopy
01/31/2023
Lisa Kuhns, PhD, MD
Researchers aimed to perform a clinical and histopathologic evaluation of 41 pediatric GA cases in a retrospective study.
Researchers aimed to perform a clinical and histopathologic evaluation of 41 pediatric GA cases in a retrospective study.
Researchers aimed to perform a...
01/31/2023
The Dermatologist
News
Tobacco Exposure Linked to Childhood Psoriasis
12/23/2021
Lauren Mateja
A study in Pediatric Dermatology found that environmental tobacco smoke exposure at home was associated with childhood psoriasis in a Turkish population study.
A study in Pediatric Dermatology found that environmental tobacco smoke exposure at home was associated with childhood psoriasis in a Turkish population study.
A study in Pediatric Dermatology...
12/23/2021
The Dermatologist
News
Paraben Exposure Increases Atopic Dermatitis Prevalence in Young Children
12/18/2021
Lisa Kuhns, PhD, MD
High exposure to parabens in children aged 0 to 3 years increased the prevalence of atopic dermatitis (AD), according to a recent study from Japan.
High exposure to parabens in children aged 0 to 3 years increased the prevalence of atopic dermatitis (AD), according to a recent study from Japan.
High exposure to parabens in...
12/18/2021
The Dermatologist
News
Atopic Dermatitis Associated With Shorter Stature and Higher BMI in Children
12/13/2021
Lisa Kuhns, PhD, MD
Atopic dermatitis in children is associated with shorter stature, higher BMI, and lower weight in early childhood, but these associations resolve with age.
Atopic dermatitis in children is associated with shorter stature, higher BMI, and lower weight in early childhood, but these associations resolve with age.
Atopic dermatitis in children is...
12/13/2021
The Dermatologist
News
Pediatric Urticaria Resolution Associated With Elevated CD63 Levels and Thyroid Comorbidity
04/13/2021
Elevated CD63 levels and thyroid disease are associated with chronic inducible urticaria (CIndU) resolution in pediatric patients.
Elevated CD63 levels and thyroid disease are associated with chronic inducible urticaria (CIndU) resolution in pediatric patients.
Elevated CD63 levels and thyroid...
04/13/2021
The Dermatologist
AD
FDA Alerts
FDA Approves Opzelura for Atopic Dermatitis in Children Aged 2–11
09/18/2025
Riya Gandhi, MA
US FDA approved Opzelura (ruxolitinib) cream 1.5% for the short-term and noncontinuous chronic treatment of mild-to-moderate AD in nonimmunocompromised children aged 2 years and older.
US FDA approved Opzelura (ruxolitinib) cream 1.5% for the short-term and noncontinuous chronic treatment of mild-to-moderate AD in nonimmunocompromised children aged 2 years and older.
US FDA approved Opzelura...
09/18/2025
The Dermatologist
FDA Alerts
Anzupgo Available for Prescribing Today
09/08/2025
Coleen Stern, MA
FDA recently approved delgocitinib cream as the first and only treatment indicated for moderate-to-severe chronic hand eczema in adults.
FDA recently approved delgocitinib cream as the first and only treatment indicated for moderate-to-severe chronic hand eczema in adults.
FDA recently approved...
09/08/2025
The Dermatologist
psoriatic arthritis
News
Rare Case Highlights Diagnostic and Treatment Challenges in PsA–Myopathy Overlap
09/02/2025
Jessica Garlewicz
The case study, accompanied by a review of 17 similar reports, details shared immunopathogenesis and conflicting treatment responses in this rare overlap syndrome.
The case study, accompanied by a review of 17 similar reports, details shared immunopathogenesis and conflicting treatment responses in this rare overlap syndrome.
The case study, accompanied by a...
09/02/2025
The Dermatologist
psoriatic arthritis
News
Real-World Data Support ITABIO Guidelines for Second-Line Biologic Use in Inflammatory Arthritis
09/02/2025
Jessica Garlewicz
The study evaluated treatment patterns and patient characteristics to assess the impact of these guidelines in real-world care.
The study evaluated treatment patterns and patient characteristics to assess the impact of these guidelines in real-world care.
The study evaluated treatment...
09/02/2025
The Dermatologist
psoriasis
News
Study Links Hypothyroidism to Psoriasis, Independent of Disease Severity
09/02/2025
Jessica Garlewicz
The findings suggest that thyroid abnormalities may represent an independent comorbidity, rather than a direct consequence of psoriasis severity.
The findings suggest that thyroid abnormalities may represent an independent comorbidity, rather than a direct consequence of psoriasis severity.
The findings suggest that...
09/02/2025
The Dermatologist
psoriasis
News
Beta-Blockers Not Linked to Increased Psoriasis Risk, Study Finds
09/02/2025
Jessica Garlewicz
A new multi-method analysis challenges long-standing concerns regarding beta-blockers and their role in triggering or worsening psoriasis.
A new multi-method analysis challenges long-standing concerns regarding beta-blockers and their role in triggering or worsening psoriasis.
A new multi-method analysis...
09/02/2025
The Dermatologist
psoriasis
News
Study Finds Distinct Psychosocial Burdens in Early- vs Late-Onset Psoriasis
08/14/2025
Jessica Garlewicz
A new cross-sectional study comparing early-onset and late-onset psoriasis highlights key clinical and psychosocial differences that may inform individualized care strategies for dermatologists.
A new cross-sectional study comparing early-onset and late-onset psoriasis highlights key clinical and psychosocial differences that may inform individualized care strategies for dermatologists.
A new cross-sectional study...
08/14/2025
The Dermatologist
psoriasis
News
Study Highlights Emerging Role of Stem Cells in Psoriasis Pathogenesis
08/14/2025
Jessica Garlewicz
Psoriasis is traditionally understood as a T cell–mediated disease, driven largely by Th1 and Th17 cell activation and impaired regulatory T cell (T-reg) function.
Psoriasis is traditionally understood as a T cell–mediated disease, driven largely by Th1 and Th17 cell activation and impaired regulatory T cell (T-reg) function.
Psoriasis is traditionally...
08/14/2025
The Dermatologist
psoriasis
News
Comorbidity Patterns in Moderate-to-Severe Psoriasis Highlight Need for Integrated Clinical Management
07/22/2025
Jessica Garlewicz
By incorporating comorbidity surveillance into dermatologic care, clinicians can improve disease control, minimize therapeutic risks, and enhance overall patient quality of life.
By incorporating comorbidity surveillance into dermatologic care, clinicians can improve disease control, minimize therapeutic risks, and enhance overall patient quality of life.
By incorporating comorbidity...
07/22/2025
The Dermatologist
psoriatic arthritis
News
TNF Inhibitors Improve Clinical Outcomes in csDMARD-Inadequate Psoriatic Arthritis, Review Finds
07/22/2025
Jessica Garlewicz
For practicing dermatologists, these findings reinforce current guidelines that position TNF inhibitors as a first-line biologic option for patients with active psoriatic arthritis.
For practicing dermatologists, these findings reinforce current guidelines that position TNF inhibitors as a first-line biologic option for patients with active psoriatic arthritis.
For practicing dermatologists,...
07/22/2025
The Dermatologist

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use